C Fan, C Wu, L Luan,
J Chen, T Sun - Journal of Molecular Structure, 2025 - Elsevier
Ensitrelvir is a 3CLpro inhibitor developed by SHIONOGI & CO., Ltd. of Japan for the
treatment of COVID-19 and was approved for marketing in Japan on November 1, 2022 …